Skip to content

Monday, November 9th, 2009

Ixempra: New Metastatic Breast Cancer Treatment Approved by the FDA

October 23, 2007 by Gloria Gamat  
Filed under Diseases & Conditions

Ixempra: New Metastatic Breast Cancer Treatment Approved by the FDA

Cancer is said to be metastatic once cancer in one body spreads to other body parts. In lay man’s term, the spreading of cancer to other locations.
When cancer becomes metastatic, it becomes an advanced stage cancer that is most often difficult to treat because the cancer becomes unresponsive to typical treatment.
Like metastatic breast cancer that becomes unresponsive to two chemotherapy treatments that include an anthracycline (such as doxorubicin or epirubicin) and a taxane (such as paclitaxel or docetaxel).
This is where new anti-cancer treatment Ixempra comes in that is recently approved by the FDA.
The approval of Ixempra includes the following:

for use …read more


About Us | Advertise with us | Blog for Blisstree | Privacy Policy | Terms of Use
Get This Theme | Sitemap


All content is Copyright © 2005-2009 b5media. All rights reserved.